Labcorp (LH) CFO Julia Aijun Wang details RSU vesting and tax share withholding

Rhea-AI Filing Summary

Labcorp Holdings Inc. (LH) Chief Financial Officer and EVP Julia Aijun Wang reported equity compensation activity on February 6, 2026. 893 Restricted Stock Units vested and converted into 893 shares of common stock, consistent with a multi-year vesting schedule that began on February 6, 2025.

To cover tax withholding obligations, 254 of these shares were withheld at a price of $277.2 per share, leaving 1,202.239 shares of common stock beneficially owned directly after the transactions. Wang also directly holds 3,474 Restricted Stock Units, each representing the right to receive one share of Labcorp common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wang Julia Aijun

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer, EVP

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/06/2026		M		893	A	(1)	1,456.239	D
Common Stock	02/06/2026		F(2)		254	D	$277.2	1,202.239	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/06/2026		M			893	(3)	(3)	Common Stock	893	$0	3,474(4)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Julia Aijun Wang	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Labcorp (LH) CFO Julia Aijun Wang report?

Julia Aijun Wang reported vesting of 893 Restricted Stock Units, which converted into 893 Labcorp common shares. On the same date, 254 shares were withheld to satisfy tax withholding obligations, and the remaining shares continued to be held directly.

How many Labcorp (LH) common shares does the CFO own after this Form 4?

After the reported transactions, Julia Aijun Wang beneficially owns 1,202.239 shares of Labcorp common stock directly. This figure reflects the 254 shares withheld for taxes and represents her post-transaction direct common share holdings.

What does the Labcorp (LH) Form 4 say about the CFO’s Restricted Stock Units?

The Form 4 shows that 893 Restricted Stock Units vested on February 6, 2026, and that Wang now holds 3,474 Restricted Stock Units in total. Each unit represents a contingent right to receive one Labcorp common share in the future.

Why were some Labcorp (LH) shares withheld in the CFO’s Form 4 filing?

The filing states that 254 Labcorp common shares were withheld as stock withholding to satisfy tax withholding obligations. This means a portion of the vested shares was retained instead of cash being used to pay related taxes.

How do the Labcorp (LH) CFO’s RSUs vest according to the Form 4?

The vesting RSUs were part of a grant that vests in three equal annual installments beginning on February 6, 2025. The February 6, 2026 vesting reflects the second installment under this multi-year equity compensation schedule.

Is the Labcorp (LH) CFO’s Form 4 transaction an open-market stock purchase or sale?

No, the Form 4 describes equity compensation activity, not an open-market trade. Shares arose from Restricted Stock Unit vesting, coded as transaction type “M,” with some shares withheld under code “F” for tax obligations.